Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > L Camille Bedrosian > Profile

L Camille Bedrosian

Affiliations

  • Chief Medical Officer at Amylyx Pharmaceuticals Inc. (AMLX), 2024-04-19
  • Director at Rhythm Pharmaceuticals Inc. (RYTM), 2023-06-23
  • Director at Crinetics Pharmaceuticals Inc. (CRNX), 2023-06-21
  • Evp And Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), 2023-03-04
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Ultragenyx Pharmaceutical Inc.
 RARE $45.25 3,881 Officer 46,720 2023-03-01 Filing
Ultragenyx Pharmaceutical Inc.
 RARE $66.62 2,821 Officer 33,938 2022-03-01 Filing
Ultragenyx Pharmaceutical Inc.
 RARE $66.30 1,657 Officer 36,759 2022-01-30 Filing
Ultragenyx Pharmaceutical Inc.
 RARE $81.14 359 Officer 38,416 2021-10-14 Filing
Ultragenyx Pharmaceutical Inc.
 RARE $100.18 2,500 Officer 38,775 2021-09-02 Filing